We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
-4.77%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$9.18B
AUM Growth
+$9.17B
Cap. Flow
+$584M
Cap. Flow %
6.37%
Top 10 Hldgs %
45.15%
Holding
683
New
55
Increased
230
Reduced
239
Closed
78

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$48.9M
2
ONON icon
On Holding
ONON
+$28.6M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$25.4M
4
UBS icon
UBS Group
UBS
+$13.8M
5
ABBV icon
AbbVie
ABBV
+$12.5M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$12.8M
2
LOGI icon
Logitech
LOGI
+$12.1M
3
BABA icon
Alibaba
BABA
+$11.4M
4
EVGO icon
EVgo
EVGO
+$8.47M
5
FIS icon
Fidelity National Information Services
FIS
+$7.31M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 23.69%
2 Healthcare 19.93%
3 Communication Services 10.22%
4 Consumer Staples 9.9%
5 Technology 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HD icon
76
Home Depot
HD
$353B
$14.4M 0.16%
52,196
-2,349
-4% -$693K
LYB icon
77
LyondellBasell Industries
LYB
$20.7B
$14.3M 0.16%
189,509
+21,007
+12% +$1.77M
BAX icon
78
Baxter International
BAX
$14.3B
$14M 0.15%
260,669
+2,940
+1% +$177K
EXAS
79
DELISTED
Exact Sciences
EXAS
$13.7M 0.15%
422,205
-1,692
-0.4% -$69.8K
ADSK icon
80
Autodesk
ADSK
$53.1B
$13.7M 0.15%
73,145
-1,228
-2% -$248K
VRTX icon
81
Vertex Pharmaceuticals
VRTX
$134B
$13.5M 0.15%
46,553
-14,145
-23% -$4.07M
BSX icon
82
Boston Scientific
BSX
$74.2B
$12.7M 0.14%
326,795
-7,351
-2% -$295K
QQQ icon
83
Invesco QQQ Trust
QQQ
$478B
$12.5M 0.14%
46,918
-4,554
-9% -$1.37M
MNST icon
84
Monster Beverage
MNST
$89.2B
$12.5M 0.14%
574,324
-32,712
-5% -$754K
LOGI icon
85
Logitech
LOGI
$14.8B
$12.5M 0.14%
267,370
-231,071
-46% -$12.1M
PFE icon
86
Pfizer
PFE
$152B
$12.4M 0.14%
284,299
+106,763
+60% +$5.19M
PYPL icon
87
PayPal
PYPL
$50.5B
$12.4M 0.14%
144,277
-2,444
-2% -$217K
INDA icon
88
iShares MSCI India ETF
INDA
$6.6B
$12.4M 0.14%
303,944
+15,911
+6% +$672K
BIIB icon
89
Biogen
BIIB
$30.1B
$12.1M 0.13%
45,175
+6,924
+18% +$1.47M
TJX icon
90
TJX Companies
TJX
$172B
$11.9M 0.13%
192,008
-1,158
-0.6% -$72.7K
APLS
91
DELISTED
Apellis Pharmaceuticals
APLS
$11.5M 0.13%
168,971
-10,579
-6% -$626K
CI icon
92
Cigna
CI
$72.4B
$10.8M 0.12%
38,788
+16,034
+70% +$4.51M
MU icon
93
Micron Technology
MU
$981B
$10.7M 0.12%
213,877
-77,666
-27% -$4.5M
ETSY icon
94
Etsy
ETSY
$7.29B
$10.7M 0.12%
106,419
+61,420
+136% +$6.27M
VGK icon
95
Vanguard FTSE Europe ETF
VGK
$31B
$10.6M 0.12%
230,749
+323
+0.1% +$16.9K
NEM icon
96
Newmont
NEM
$124B
$10.5M 0.11%
250,782
+16,147
+7% +$754K
AZN icon
97
AstraZeneca
AZN
$246B
$10.3M 0.11%
94,289
-653
-0.7% -$82.8K
WM icon
98
Waste Management
WM
$90.7B
$10M 0.11%
62,479
+10,127
+19% +$1.67M
EW icon
99
Edwards Lifesciences
EW
$54B
$10M 0.11%
121,106
-13,593
-10% -$1.31M
NSC icon
100
Norfolk Southern
NSC
$75.2B
$9.83M 0.11%
+46,881
New +$11.3M
2 3
4
5 6

Similar funds

MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $15.7B AUM 30.78% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
LCIP
Life Cycle Investment Partners London $15.7B AUM
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Banque Pictet & Cie's Q3 2022 Portfolio in Review

As of Q3 2022, Banque Pictet & Cie held 683 positions worth $9.18B, up 90,716% from $10.1M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Banque Pictet & Cie deployed $584M of net new capital in Q3 2022, opening 55 new positions and adding to 230 existing holdings. Its largest new stake was Norfolk Southern: 46,881 shares worth $9.83M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $12.8M trimmed.

  • Banque Pictet & Cie's largest Q3 2022 buy was Norfolk Southern: 46,881 shares worth $9.83M.
  • Banque Pictet & Cie added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $48.9M increase.
  • Banque Pictet & Cie's biggest Q3 2022 reduction was Idexx Laboratories, cutting an estimated $12.8M.
  • Banque Pictet & Cie fully exited State Street SPDR Bloomberg Convertible Securities ETF in Q3 2022, selling an estimated $35.6K.
  • Banque Pictet & Cie's ten largest holdings make up 45% of its $9.18B portfolio in Q3 2022.
  • Banque Pictet & Cie opened 55 new positions and closed 78 in Q3 2022.
  • Banque Pictet & Cie's portfolio value rose 90,716% quarter-over-quarter to $9.18B.

Based on Banque Pictet & Cie's 13F filing for Q3 2022, filed 10 Nov 2022.